Natixis Advisors, L.P. Baxter International Inc Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Baxter International Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 931,214 shares of BAX stock, worth $33.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

931,214

Previous 438,113 112.55%

Holding current value

$33.6 Million

Previous $14.7 Million 141.27%

% of portfolio

0.07%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$32.85 - $40.26 $16.2 Million - $19.9 Million	493,101 Added 112.55%	931,214 $35.4 Million
Q2 2024 Aug 01, 2024	SELL	$32.87 - $43.55 $8.46 Million - $11.2 Million	-257,307 Reduced 37.0%	438,113 $14.7 Million
Q1 2024 Apr 25, 2024	BUY	$37.88 - $43.77 $1.29 Million - $1.48 Million	33,927 Added 5.13%	695,420 $29.7 Million
Q4 2023 Feb 06, 2024	BUY	$31.71 - $38.95 $5.38 Million - $6.61 Million	169,805 Added 34.54%	661,493 $25.6 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $116,736 - $154,179	-3,128 Reduced 0.63%	491,688 $18.6 Million
Q2 2023 Aug 15, 2023	BUY	$39.98 - $47.68 $1.22 Million - $1.46 Million	30,623 Added 6.6%	494,816 $22.5 Million
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $9.42 Million - $13.2 Million	250,703 Added 117.43%	464,193 $18.8 Million
Q4 2022 Jan 27, 2023	BUY	$49.7 - $57.71 $6.01 Million - $6.98 Million	120,986 Added 130.79%	213,490 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $2.7 Million - $3.35 Million	50,199 Added 118.66%	92,504 $4.98 Million
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $646,470 - $810,240	-10,128 Reduced 19.32%	42,305 $2.72 Million
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $275,353 - $320,499	-3,583 Reduced 6.4%	52,433 $4.07 Million
Q4 2021 Feb 08, 2022	BUY	$74.57 - $87.19 $952,482 - $1.11 Million	12,773 Added 29.54%	56,016 $4.81 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $294,416 - $333,687	-3,991 Reduced 8.45%	43,243 $3.48 Million
Q2 2021 Aug 12, 2021	BUY	$80.5 - $88.01 $350,980 - $383,723	4,360 Added 10.17%	47,234 $3.8 Million
Q1 2021 May 05, 2021	SELL	$76.38 - $86.03 $708,959 - $798,530	-9,282 Reduced 17.8%	42,874 $3.62 Million
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $96,499 - $105,420	-1,280 Reduced 2.4%	52,156 $4.19 Million
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $427,290 - $494,932	-5,455 Reduced 9.26%	53,436 $4.3 Million
Q2 2020 Aug 11, 2020	SELL	$78.66 - $94.14 $695,905 - $832,856	-8,847 Reduced 13.06%	58,891 $5.07 Million
Q1 2020 Apr 27, 2020	BUY	$71.57 - $93.3 $671,684 - $875,620	9,385 Added 16.08%	67,738 $5.5 Million
Q4 2019 Feb 10, 2020	BUY	$76.7 - $88.45 $581,539 - $670,627	7,582 Added 14.93%	58,353 $4.88 Million
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $133,496 - $147,239	-1,640 Reduced 3.13%	50,771 $4.44 Million
Q2 2019 Aug 12, 2019	SELL	$73.44 - $82.41 $744,901 - $835,884	-10,143 Reduced 16.21%	52,411 $4.29 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $3.55 Million - $4.47 Million	-55,004 Reduced 46.79%	62,554 $5.09 Million
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $407,352 - $515,736	-6,629 Reduced 5.34%	117,558 $7.74 Million
Q3 2018 Nov 13, 2018	BUY	$70.71 - $77.75 $20,435 - $22,469	289 Added 0.23%	124,187 $9.57 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $40,087 - $47,659	-632 Reduced 0.51%	123,898 $0
Q1 2018 May 10, 2018	SELL	$62.56 - $72.26 $1.26 Million - $1.46 Million	-20,199 Reduced 13.96%	124,530 $8.1 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $435,864 - $468,492	-7,093 Reduced 4.67%	144,729 $9.36 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $9.03 Million - $9.81 Million	151,822	151,822 $9.53 Million

Others Institutions Holding BAX

# of Institutions

996

Shares Held

449M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Baxter International Inc Transaction History